These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1721008)

  • 1. Aflatoxin B1-DNA adducts and hepatitis B virus antigens in hepatocellular carcinoma and non-tumorous liver tissue.
    Zhang YJ; Chen CJ; Lee CS; Haghighi B; Yang GY; Wang LW; Feitelson M; Santella R
    Carcinogenesis; 1991 Dec; 12(12):2247-52. PubMed ID: 1721008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical detection of aflatoxin B1-DNA adducts and hepatitis B virus antigens in hepatocellular carcinoma and nontumorous liver tissue.
    Santella RM; Zhang YJ; Chen CJ; Hsieh LL; Lee CS; Haghighi B; Yang GY; Wang LW; Feitelson M
    Environ Health Perspect; 1993 Mar; 99():199-202. PubMed ID: 8391434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.
    Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM
    Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aflatoxin B1 DNA adducts in smeared tumor tissue from patients with hepatocellular carcinoma.
    Chen CJ; Zhang YJ; Lu SN; Santella RM
    Hepatology; 1992 Nov; 16(5):1150-5. PubMed ID: 1385290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
    Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
    Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preparation of monoclonal antibody directed against hepatitis B virus X protein and detection of reactive antigen in hepatocellular carcinoma].
    Li J; Tang ZY; Liu KD; Schroder CH
    Zhonghua Yi Xue Za Zhi; 1994 Sep; 74(9):533-5, 582. PubMed ID: 7842349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma antioxidant vitamins, chronic hepatitis B virus infection and urinary aflatoxin B1-DNA adducts in healthy males.
    Yu MW; Chiang YC; Lien JP; Chen CJ
    Carcinogenesis; 1997 Jun; 18(6):1189-94. PubMed ID: 9214602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer.
    Wang WL; London WT; Feitelson MA
    Cancer Res; 1991 Sep; 51(18):4971-7. PubMed ID: 1654208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts.
    Yu MW; Lien JP; Liaw YF; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):613-9. PubMed ID: 8824363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of aflatoxin B1-DNA adducts in woodchuck hepatocytes and rat liver tissue by indirect immunofluorescence analysis.
    Zhang YJ; Chen CJ; Haghighi B; Yang GY; Hsieh LL; Wang LW; Santella RM
    Cancer Res; 1991 Mar; 51(6):1720-5. PubMed ID: 1900216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunohistochemical study on X antigen of HBV (HBxAg) in primary hepatic carcinoma].
    Wang WL
    Zhonghua Zhong Liu Za Zhi; 1992 Sep; 14(5):331-3. PubMed ID: 1337887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma.
    Feitelson MA; Zhu M; Duan LX; London WT
    Oncogene; 1993 May; 8(5):1109-17. PubMed ID: 8386823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does aflatoxin B1 play a role in the etiology of hepatocellular carcinoma in the United States?
    Hoque A; Patt YZ; Yoffe B; Groopman JD; Greenblatt MS; Zhang YJ; Santella RM
    Nutr Cancer; 1999; 35(1):27-33. PubMed ID: 10624703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological detection of aflatoxin B1-DNA adducts formed in vivo.
    Hsieh LL; Hsu SW; Chen DS; Santella RM
    Cancer Res; 1988 Nov; 48(22):6328-31. PubMed ID: 3141043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aflatoxin B
    Chu YJ; Yang HI; Wu HC; Lee MH; Liu J; Wang LY; Lu SN; Jen CL; You SL; Santella RM; Chen CJ
    Eur J Cancer; 2018 May; 94():37-46. PubMed ID: 29533866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.
    Qi LN; Bai T; Chen ZS; Wu FX; Chen YY; De Xiang B; Peng T; Han ZG; Li LQ
    Liver Int; 2015 Mar; 35(3):999-1009. PubMed ID: 24461059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of hepatitis B x antigen as a prognostic marker in the development of hepatocellular carcinoma.
    Zhu M; London WT; Duan LX; Feitelson MA
    Int J Cancer; 1993 Oct; 55(4):571-6. PubMed ID: 8406983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma.
    Chen CJ; Yu MW; Liaw YF; Wang LW; Chiamprasert S; Matin F; Hirvonen A; Bell DA; Santella RM
    Am J Hum Genet; 1996 Jul; 59(1):128-34. PubMed ID: 8659516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of colocalization of HBxAg and insulin like growth factor II in the livers of patients with chronic hepatitis B, cirrhosis and hepatocellular carcinoma.
    Seo JH; Kim KW; Murakami S; Park BC
    J Korean Med Sci; 1997 Dec; 12(6):523-31. PubMed ID: 9443091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts.
    Denissenko MF; Koudriakova TB; Smith L; O'Connor TR; Riggs AD; Pfeifer GP
    Oncogene; 1998 Dec; 17(23):3007-14. PubMed ID: 9881702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.